Search

Your search keyword '"Verkooijen, Helena M."' showing total 286 results

Search Constraints

Start Over You searched for: Author "Verkooijen, Helena M." Remove constraint Author: "Verkooijen, Helena M." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
286 results on '"Verkooijen, Helena M."'

Search Results

1. Quality of life of women with a screen-detected versus clinically detected breast cancer in the Netherlands: a prospective cohort study

2. The Value of Biological and Conditional Factors for Staging of Patients with Resectable Pancreatic Cancer Undergoing Upfront Resection: A Nationwide Analysis

3. Generative Models for Reproducible Coronary Calcium Scoring

4. Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design - A scoping review

9. Preoperative Magnetic Resonance Guided Single-Dose Partial Breast Irradiation: 5-Year Results of the Prospective Single-Arm ABLATIVE Trial

10. Physical and mental health of breast cancer patients and survivors before and during successive SARS-CoV-2-infection waves

12. Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study

13. Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer

14. Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study—An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy

16. Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer

21. Focused Ultrasound and RadioTHERapy for non-invasive palliative pain treatment in patients with bone metastasis: a study protocol for the three armed randomized controlled FURTHER trial

23. Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma

26. The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer

28. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance–Guided Radiotherapy

29. Randomised trials conducted using cohorts: a scoping review

30. Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry

32. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy

33. Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases: A Systematic Review and Meta-Analysis

34. Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost

35. MRI-guided radiotherapy in twenty fractions for localised prostate cancer: results from the MOMENTUM study

36. Hyperbaric Oxygen Therapy and Late Local Toxic Effects in Patients With Irradiated Breast Cancer: A Randomized Clinical Trial

37. The Value of Biological and Conditional Factors for Staging of Patients with Resectable Pancreatic Cancer Undergoing Upfront Resection:A Nationwide Analysis

40. Correction to: Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer

41. ASO Visual Abstract: Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer

42. Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost

44. External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer: Outcome of Eligible but Nonrandomized Patients

46. Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac

49. 601: Eligibility for MR-HIFU in patients with non-spinal bone metastases referred for radiotherapy

Catalog

Books, media, physical & digital resources